Literature DB >> 10210246

Levels of cerebrospinal fluid nerve-growth factor differ in infantile autism and Rett syndrome.

R Riikonen1, R Vanhala.   

Abstract

Autism and Rett syndrome (RS) are both developmental disorders of unknown origin. Autism is a behaviourally defined syndrome. RS, which affects girls only, is characterized by a profound learning disability following early normal development, with a consistent cluster of clinical features. Differentiation of RS from infantile autism in the very early stages of the disorders is not always easy. Both syndromes still lack discriminative laboratory markers for accurate diagnosis and differentiation. We decided to compare the CSF nerve-growth factor (NGF) levels of children with infantile autism and children with RS using enzyme-linked immunosorbent assay (ELISA). Our findings of mainly normal CSF NGF in autism and low to negligible values in RS are in agreement with the different morphological and neurochemical findings (brain growth, affected brain areas, neurotransmitter metabolism) in the two syndromes. CSF NGF could be used as a biochemical marker for differentiation of patients with autism from those with RS.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10210246     DOI: 10.1017/s0012162299000328

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  13 in total

Review 1.  Transient receptor potential channels as novel effectors of brain-derived neurotrophic factor signaling: potential implications for Rett syndrome.

Authors:  Michelle D Amaral; Christopher A Chapleau; Lucas Pozzo-Miller
Journal:  Pharmacol Ther       Date:  2006-11-21       Impact factor: 12.310

2.  QTL replication and targeted association highlight the nerve growth factor gene for nonverbal communication deficits in autism spectrum disorders.

Authors:  A T-H Lu; J Yoon; D H Geschwind; R M Cantor
Journal:  Mol Psychiatry       Date:  2011-11-22       Impact factor: 15.992

3.  Speech and motor disturbances in Rett syndrome.

Authors:  V M Bashina; N V Simashkova; V V Grachev; N L Gorbachevskaya
Journal:  Neurosci Behav Physiol       Date:  2002 Jul-Aug

4.  Bdnf overexpression in hippocampal neurons prevents dendritic atrophy caused by Rett-associated MECP2 mutations.

Authors:  Jennifer L Larimore; Christopher A Chapleau; Shinichi Kudo; Anne Theibert; Alan K Percy; Lucas Pozzo-Miller
Journal:  Neurobiol Dis       Date:  2009-01-03       Impact factor: 5.996

5.  Modulation of dendritic spine development and plasticity by BDNF and vesicular trafficking: fundamental roles in neurodevelopmental disorders associated with mental retardation and autism.

Authors:  Christopher A Chapleau; Jennifer L Larimore; Anne Theibert; Lucas Pozzo-Miller
Journal:  J Neurodev Disord       Date:  2009-09       Impact factor: 4.025

6.  Nerve growth factor plasma levels and ventricular repolarization in Rett syndrome.

Authors:  F Guideri; M Acampa; G Calamandrei; L Aloe; M Zappella; Y Hayek
Journal:  Pediatr Cardiol       Date:  2004 Jul-Aug       Impact factor: 1.655

Review 7.  Neuronal connectivity as a convergent target of gene × environment interactions that confer risk for Autism Spectrum Disorders.

Authors:  Marianna Stamou; Karin M Streifel; Paula E Goines; Pamela J Lein
Journal:  Neurotoxicol Teratol       Date:  2012-12-23       Impact factor: 3.763

Review 8.  Insulin-Like Growth Factors in the Pathogenesis of Neurological Diseases in Children.

Authors:  Raili Riikonen
Journal:  Int J Mol Sci       Date:  2017-09-26       Impact factor: 5.923

Review 9.  Delineating the Common Biological Pathways Perturbed by ASD's Genetic Etiology: Lessons from Network-Based Studies.

Authors:  Oded Oron; Evan Elliott
Journal:  Int J Mol Sci       Date:  2017-04-14       Impact factor: 5.923

10.  Serum nerve growth factor levels in autistic children in Turkish population: a preliminary study.

Authors:  Nida Dinçel; Aycan Ünalp; Ayşe Kutlu; Aysel Öztürk; Nedret Uran; Sadık Ulusoy
Journal:  Indian J Med Res       Date:  2013-12       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.